| Disseminated Tuberculosis: A 3-Year Case-Series Experience in a Tertiary Care Center | Canan GÜNDÜZ,Hamide ŞEKERBEY,Aylin BABALIK | 358–363 |
| Is ASA Classification Useful in Risk Stratification for EBUS-TBNA? | İlker ÖNGÜÇ, Hülya KAHRAMAN, Ömer ÖZBUDAK, Hülya DİROL | 364–368 |
| 30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity | Aylin özgen APAYDIN,Saliha Selin ÖZUYGUR,Ceyda SAHAN,Kemal Can TERTEMİZ,Richard RUSSELL | 369–375 |
| Regular Treatment With Aspirin 300 mg/day After Desensitization in Patients With N-ERD: 12-Year Results | Saltuk Buğra KAYA,Mehmet Erdem ÇAKMAK,Ebru ÇELEBİOĞLU,Gül KARAKAYA,Ali Fuat KALYONCU | 376–380 |
| Old Habits Die Hard – Asbestos Exposure | Barış ÇİL,Mehmet Reşit POLAT,Mehmet KABAK | 381–385 |
| Validity and Reliability of Turkish Version of Reaction Type Scale Against COPD | Hakan GÜNEN, Nermin GÜRHAN, Selma AYDOĞAN EROĞLU, Burak ŞİRİN, Emel KAYA, Nurdan KÖKTÜRK, Ülkü POLAT | 386–392 |
| Five-Year Trends in Direct Costs of Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-3 | Tarkan ÖZDEMİR,Hatice KİLİC,Nilgun Yilmaz DEMİRCİ,Çiğdem ÖZDİLEKCAN,GÜVEN BEKTEMÜR,Mustafa Hamidullah TÜRKKANI,Simten MALHAN,H. Canan HASANOĞLU,Can ÖZTÜRK,Orhan KOÇ | 393–398 |
| The Effect of Education and Motivational Interviewing on COPD Management and Outcome Parameters in COPD Patients | DERYA TÜLÜCE,Nurdan KÖKTÜRK,Bahadır GENİŞ,Aycan KAYALAR,Nermin GÜRHAN,Sevinç KUTLUTURKAN | 399–406 |
| Perceptions of Students of a Medical School on Combined Health Warnings in Plain Packs | Yeşim YASİN,Nilüfer AYKAÇ | 407–412 |
| Fetal Programming: Lung Health and Disease | Ozge YİLMAZ,HASAN YÜKSEL,A Sonia BUİST | 413–417 |
| Isolated Pulmonary Cysticercosis Presenting as Mass Lesion | Parul MRİGPURİ,Vatsal Bhushan GUPTA,Balakrishnan MENON,Sonam SPALGAİS,Raj KUMAR | 418–421 |
| War in the Time of COVID-19: A Humanitarian Catastrophe in Nagorno-Karabakh and Armenia |